De Conno F , Ripamonti C , Brunelli C . Opioid purchases and expenditure in nine western European countries: ‘Are we killing off morphine? ’ Palliat Med2005; 19: 179–184 .
2.
De Lima L , Sweeney C , Palmer JL , Bruera E . Potent analgesics are more expensive for patients in developing countries: a comparative study . J Pain Palliat Care Pharmacother2004; 19: 59–70 .
3.
Stjernsward J , Bruera E , Joranson D , et al. Opioid availability in Latin America: the declaration of Florianopolis . J Palliat Care1994; 10: 11–14 .
4.
De Lima L , Bruera E , Joranson D , Vanegas G , Cepeda S , Quesada L . Opioid availability in Latin America: the Santo Domingo report – progress since the declaration of Florianopolis . J Pain Symptom Manage1997; 13: 213–219 .
5.
Ripamonti C . Pharmacology of opioid analgesia: clinical principals. In Bruera E , Portenoy RK eds. Cancer pain assessment and management. Cambridge, UK: Cambridge University Press , 2003.
6.
Ripamonti C . Methadone: an orphan drug?J Palliat Med2004; 7: 73–74 .
7.
Bruera E , Palmer JL , Bosnjak S , et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized double-blind study . J Clin Oncol2004; 22: 185–192 .
